• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.14% Nasdaq Down0.35%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    39.13 Up 1.06(2.78%) Sep 3, 4:00PM EDT
    |After Hours : 38.51 Down 0.62 (1.58%) Sep 3, 5:57PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 1   4   48   14  
    Cost of Revenue -   -   -   -  
    Gross Profit 1   4   48   14  
    Operating Expenses
    Research Development18,379  16,295  18,182  16,953  
    Selling General and Administrative21,119  24,261  10,420  8,056  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (39,497) (40,552) (28,554) (24,995)
    Income from Continuing Operations
    Total Other Income/Expenses Net119  177  188  209  
    Earnings Before Interest And Taxes(39,378)(40,375)(28,366)(24,786)
    Interest Expense -   -   -   -  
    Income Before Tax(39,378)(40,375)(28,366)(24,786)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(39,378)(40,375)(28,366)(24,786)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (39,378) (40,375) (28,366) (24,786)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (39,378) (40,375) (28,366) (24,786)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.